The incidence and nature of prescribing and medication administration errors in paediatric inpatients

Maisoon Abdullah Ghaleb1, Nick Barber, Bryony Dean Franklin

  • 1Department of Practice and Policy, The School of Pharmacy, University of Hertfordshire, Hatfield AL10 9AB, UK. m.ghaleb@herts.ac.uk

Insights

Medication errors are frequent in pediatric care, with 13.2% of prescriptions and 19.1% of administrations being erroneous. These prescribing and medication administration errors highlight challenges in pediatric patient care.

Area of Science:

  • Pediatric Patient Safety
  • Medication Error Research
  • Healthcare Quality Improvement

Background:

  • Medication errors pose a significant risk to patient safety, particularly in vulnerable pediatric populations.
  • Understanding the incidence and nature of these errors is crucial for developing effective interventions.

Purpose of the Study:

  • To determine the incidence and types of prescribing errors in pediatric inpatients.
  • To identify the frequency and nature of medication administration errors in pediatric care.

Main Methods:

  • Prospective review of drug charts for prescribing errors.
  • Direct observation of medication preparation and administration for administration errors.
  • Analysis of incident reports from pediatric wards across five London hospitals.

Main Results:

  • A prescribing error rate of 13.2% was identified, with incomplete prescriptions being most common.
  • A medication administration error rate of 19.1% was observed, with drug preparation errors being most frequent.
  • Significant variation in error rates was noted between different hospital wards.

Conclusions:

  • Prescribing and medication administration errors are common in pediatric settings.
  • Unique challenges in pediatric prescribing and administration contribute to error rates.
  • Local investigation and targeted improvement strategies are necessary to reduce medication errors in pediatric patients.
Abstract

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...